Why the study?
Do antihypertensive medications reduce left ventricular mass in patients with hypertension and LVH?
Do antihypertensive medications reduce left ventricular mass in patients with hypertension and LVH?
Answers are grounded in this paper and cite their sources.
Antihypertensive treatments effectively reverse left ventricular hypertrophy, which is a major predictor of cardiovascular morbidity and mortality.
Numerous studies have established a close link between left ventricular hypertrophy (LVH) detected by electrocardiogram (ECG) and, more recently, echocardiogram and the risk of cardiovascular morbidity and mortality. In fact, increased echocardiographic LV mass has been shown to predict complications in both members of the general population¹and patients with hypertension²more strongly than any other risk factor except advancing age. These findings have led to widespread acceptance of the idea that established LVH should be reversed by treatment. The effects on LVH of antihypertensive treatments alone have been studied in nearly 500 human trials and an even larger number of experimental ones. See also p 1507. What Have We Learned So Far? The clear conclusion from this line of research is that LV mass decreases if blood pressure is substantially reduced by most classes of antihypertensive medications, with the possible exception of directly acting vasodilators.³,⁴Intensive
No takes yet. Share an insight, caveat, or question.
Richard B. Devereux (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: